A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer
A phase 2 trial of FLOT, Bevacizumab, Cetuximab in colorectal cancer, run by Multitude Therapeutics Inc., now recruiting.
Overview
A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer is a phase 2 interventional study registered as NCT07474727 by Multitude Therapeutics Inc., with 180 participants planned, started 2026-04-29 and due to reach its primary completion in 2027-09-30. Interventions recorded: AMT-676, 5-FU, Leucovorin, Bevacizumab, Cetuximab. Conditions listed: Colorectal Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialHSK42360-Na Tablets Combined With Cetuximab With or Without Chemotherapy in BRAF V600-Mutant Metastatic Colorectal Cancer
Shares FOLFIRI (5-FU, leucovorin, irinotecan), FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin), Cetuximab.
- TrialA Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
Shares FOLFIRI (5-FU, leucovorin, irinotecan), FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), Bevacizumab, Colorectal cancer.
- TrialA Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
Shares FOLFIRI (5-FU, leucovorin, irinotecan), FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin), Colorectal cancer.
- TrialA Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard
Shares FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin), Bevacizumab, Colorectal cancer.
- TrialA Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Parti
Shares FOLFIRI (5-FU, leucovorin, irinotecan), CAPOX (capecitabine, oxaliplatin), Bevacizumab, Colorectal cancer.
- TrialA Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer
Shares FOLFIRI (5-FU, leucovorin, irinotecan), FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin), Colorectal cancer.
- TrialPhase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Shares FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin), Colorectal cancer.
- TrialA Study of HDM2017 Combination Therapy in Advanced Colorectal Cancer
Shares FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin), Bevacizumab, Colorectal cancer.